Ann Arbor Michigan Stem Cells
16 views | +0 today
Follow
Ann Arbor Michigan Stem Cells
Clinical trials using Stem cells
Curated by Jaci
Your new post is loading...
Your new post is loading...
Scooped by Jaci
Scoop.it!

Ted Harada ALS Patient & Advocate

Ted Harada discusses why he passionately supports the National Right to Try Movement.
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Neuralstem Inc.: Neuralstem Reports Fiscal 2014 Fourth Quarter Financial And ... - The Wall Street Transcript

Neuralstem Inc.: Neuralstem Reports Fiscal 2014 Fourth Quarter Financial And ... - The Wall Street Transcript | Ann Arbor Michigan Stem Cells | Scoop.it
“An independent investment publication of Interviews with Company CEOs, Money Managers, and Wall Street Analysts.”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

BrainStorm's NurOwn Stem Cell ALS Therapy Designated “Fast-track” Product - Medgadget.com

BrainStorm's NurOwn Stem Cell ALS Therapy Designated “Fast-track” Product - Medgadget.com | Ann Arbor Michigan Stem Cells | Scoop.it
“Amyotrophic lateral sclerosis (ALS) is a devastating neuromuscular disease that progresses swiftly, causing motor neuron degeneration and subsequent muscle”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

BrainStorm reports last patient visit in Phase IIa ALS trial - Pharmaceutical Business Review

BrainStorm reports last patient visit in Phase IIa ALS trial - Pharmaceutical Business Review | Ann Arbor Michigan Stem Cells | Scoop.it
“BrainStorm Cell Therapeutics, a leading developer of adult stem cell technologies for neurodegenerative diseases, has announced that the last patient”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

FDA Grants Fast Track Designation to NurOwnb" for the Treatment of ALS - CNNMoney

FDA Grants Fast Track Designation to NurOwnb" for the Treatment of ALS - CNNMoney | Ann Arbor Michigan Stem Cells | Scoop.it
“FDA Grants Fast Track Designation to NurOwnb" for the Treatment of ALS CNNMoney ... (ALS, or Lou Gehrig's Disease).”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

CEO Richard Garr & Ted Harada nominate FDA Commissioner Hamburg for the ALS #IceBucketChallenge

“Neuralstem's CEO, Richard Garr, completed the ALS Ice Bucket Challenge with patient and advocate Ted Harada. The two nominate Commissioner Hamburg of the FDA to support ALS research and awareness.”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Interview with Ted Harada Part 2: Right To Try, Neuralstem, and How He's Doing

Interview with Ted Harada Part 2: Right To Try, Neuralstem, and How He's Doing | Ann Arbor Michigan Stem Cells | Scoop.it
“This is Part 2 of my interview with ALS and stem cell advocate, Ted Harada. You can read Part 1 on where things stand today with ALS, the FDA, and the Ice Bucket Challenge. What’s your opinion of t...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

BrainStorm shares to be listed on Nasdaq Capital Market - Reuters

“BrainStorm shares to be listed on Nasdaq Capital Market Reuters TEL AVIV (Reuters) - BrainStorm Cell Therapeutics Inc., an Israeli developer of adult stem cell treatments for neurodegenerative diseases, said its stock has been approved for listing...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Research making ALS less of a mystery - CBS News

Research making ALS less of a mystery - CBS News | Ann Arbor Michigan Stem Cells | Scoop.it
“Research making ALS less of a mystery CBS News Patients lose control of movement and eventually their ability to breathe on their own. The cause of ALS is unknown.”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

The ALS stem cell trial from a patient POV

“Ted Harada, a participant in Phase I of Dr. Eva Feldman's trial of a stem cell therapy for ALS.”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Neuralstem Inc Advocates ALS Adult Stem Cell Treatment Under ...

Neuralstem Inc Advocates ALS Adult Stem Cell Treatment Under ... | Ann Arbor Michigan Stem Cells | Scoop.it
“No one is suggesting that this process take the place of the existing clinical trial process. And no company (though I can only speak for Neuralstem) will offer a drug if the FDA tells it not to. The heart of the RTT bill recognizes ...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Team Gleason Announces Collaborative Initiative: Answer ALS - NewOrleansSaints.com

Team Gleason Announces Collaborative Initiative: Answer ALS - NewOrleansSaints.com | Ann Arbor Michigan Stem Cells | Scoop.it
“Team Gleason Announces Collaborative Initiative: Answer ALS NewOrleansSaints.com With our focus on collaboration, we will utilize the proven model of the Robert Packard Center for ALS Research to create an entirely new and expansive ALS...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

BrainStorm Announces Publication of Preclinical Multidose Study of NurOwn - SYS-CON Media (press release)

BrainStorm Announces Publication of Preclinical Multidose Study of NurOwn - SYS-CON Media (press release) | Ann Arbor Michigan Stem Cells | Scoop.it
“BrainStorm Announces Publication of Preclinical Multidose Study of NurOwn SYS-CON Media (press release) This paper describes the safety of single and repeated intramuscular administration of NurOwn, the Company's proprietary mesenchymal stem cells...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Clinical Trial Moves Stem Cell Therapy For ALS Patients One Step Closer To ... - Clinical Leader

“Stem cells are a safe therapy for patients with amyotrophic lateral sclerosis (ALS), according to the results of a recently completed phase 1...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

An Expert's Opinion On Neuralstem's Phase 2 Results (CUR) - Seeking Alpha (registration)

An Expert's Opinion On Neuralstem's Phase 2 Results (CUR) - Seeking Alpha (registration) | Ann Arbor Michigan Stem Cells | Scoop.it
“The phase 2a results of Neuralstem's (NYSEMKT:CUR) NSI-566 have raised a battle. Good or bad, the results attracted a great deal of attention.”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

The ALS Association Announces Initial Commitment of $21.7 Million from Ice ... - PR Newswire (press release)

The ALS Association Announces Initial Commitment of $21.7 Million from Ice ... - PR Newswire (press release) | Ann Arbor Michigan Stem Cells | Scoop.it
“WASHINGTON, Oct. 2, 2014 /PRNewswire-USNewswire/ -- After the generous outpouring of support from people all around...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALS - MarketWatch

FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALS - MarketWatch | Ann Arbor Michigan Stem Cells | Scoop.it
“FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALS MarketWatch NurOwn™ consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors, and is currently being studied in a randomized,...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Ted Harada Interview Part 1: Stem Cells for ALS, #IceBucketChallenge, & FDA

Ted Harada Interview Part 1: Stem Cells for ALS, #IceBucketChallenge, & FDA | Ann Arbor Michigan Stem Cells | Scoop.it
“Ted Harada is a wonderful patient advocate for the stem cell field and for the development of safe and effective stem cell products to treat ALS. Ted has ALS and received stem cell-based treatments...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Ice Buckets and IPOs: 6 biotechs targeting CNS diseases - NASDAQ

Ice Buckets and IPOs: 6 biotechs targeting CNS diseases - NASDAQ | Ann Arbor Michigan Stem Cells | Scoop.it
“Ice Buckets and IPOs: 6 biotechs targeting CNS diseases NASDAQ Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease) is a fatal neurodegenerative disease that affects about 30,000 people in the US.”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Revolutionary stem-cell ALS treatment begins advanced trials - Canada Free Press

“Revolutionary stem-cell ALS treatment begins advanced trials Canada Free Press As the Ice Bucket Challenge raises millions for research into amyotrophic lateral sclerosis (ALS), an Israeli treatment to ease symptoms and slow the progression of ALS...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data - NEWS.GNOM.ES

Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data - NEWS.GNOM.ES | Ann Arbor Michigan Stem Cells | Scoop.it
“Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data NEWS.GNOM.ES Neuralstem's NSI-566 spinal cord-derived neural stem cell therapy Phase II clinical trials for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Beyond The Ice Bucket: Excitement Builds Over US Trials Of New ALS Treatment - News 92 FM

Beyond The Ice Bucket: Excitement Builds Over US Trials Of New ALS Treatment - News 92 FM | Ann Arbor Michigan Stem Cells | Scoop.it
“News 92 FM Beyond The Ice Bucket: Excitement Builds Over US Trials Of New ALS Treatment News 92 FM The treatment harvests a patient's stem cells from their bone marrow, treats the cells with chemicals until they grow new neurons, then injects them...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

FDA enhancing access to clinical trial subgroup data CMS announces new ... - Politico

FDA enhancing access to clinical trial subgroup data CMS announces new ... - Politico | Ann Arbor Michigan Stem Cells | Scoop.it
“FDA enhancing access to clinical trial subgroup data CMS announces new ...”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Living with ALS: Looking for a cure - Richmond Times Dispatch

Living with ALS: Looking for a cure - Richmond Times Dispatch | Ann Arbor Michigan Stem Cells | Scoop.it
“Living with ALS: Looking for a cure Richmond Times Dispatch The splints help Lindley push buttons even though ALS is killing her nerve cells. Living with ALS: Looking for a cure ......”
more...
No comment yet.
Scooped by Jaci
Scoop.it!

Lou Gehrig's Sad Farewell and the Disease that Bears His Name - News from Rutgers

Lou Gehrig's Sad Farewell and the Disease that Bears His Name - News from Rutgers | Ann Arbor Michigan Stem Cells | Scoop.it
“News from Rutgers Lou Gehrig's Sad Farewell and the Disease that Bears His Name News from Rutgers On the Fourth of July 75 years ago, in 1939, legendary first baseman Lou Gehrig – afflicted with a nerve disorder called amyotrophic lateral...”
more...
No comment yet.